BriaCell Therapeutics Corp.
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LUSTIG MARC director, 10 percent owner:
Common Shares 902,935 $2.22 $2,000,001
Purchase
LUSTIG MARC director, 10 percent owner:
Common Stock Warrants 902,935 $2.11 $1,905,193
Purchase
BONDARENKO JAMIESON officer: Chairman
 Common Shares 28,000 $4.58 $128,240
Purchase
WILLIAMS WILLIAM V. officer: President, CEO
 Warrant 2,530 $1.94 $4,908
Purchase
BONDARENKO JAMIESON director
 Common Shares 22,000 $5.35 $117,700

Showing 1 to 5 of 5 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: